Description
IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES - DEOBLIGATE EXCESS FY 18 FUNDS
Base award description: IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES - FUND OPTION
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-10-01+$403,690= $403,690
- Mod P000012016-11-09-$100,000= $303,690
- Mod P000022017-10-17+$30,000= $333,690
- Mod P000032017-11-30-$135,108= $198,582
- Mod P000042017-12-21-$16,272= $182,310
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-10-01 | +$403,690 | $403,690 | IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES - FUND OPTION |
| Mod P00001· FUNDING ONLY ACTION | 2016-11-09 | −$100,000 | $303,690 | IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES - DECREASE FUNDING |
| Mod P00002· FUNDING ONLY ACTION | 2017-10-17 | +$30,000 | $333,690 | IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES - FUND 30-DAY EXTENSION |
| Mod P00003· FUNDING ONLY ACTION | 2017-11-30 | −$135,108 | $198,582 | IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES - DEOBLIGATE EXCESS FY 17 FUNDS |
| Mod P00004· OTHER ADMINISTRATIVE ACTION | 2017-12-21 | −$16,272 | $182,310 | IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES - DEOBLIGATE EXCESS FY 18 FUNDS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SCFJBJWLMXT6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626D0050 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C25626N0450 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $324,605 | FY2026 |
| 36C25626N0432 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $245,189 | FY2026 |
| 36C25626N0069 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $135,008 | FY2026 |
| 36C25625N0652 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $162,292 | FY2025 |
| 36C25625N0007 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $307,339 | FY2025 |
Other recipients under Q999 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25626F0156 | BRANCH MEDICAL LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $157,170 | FY2026 |
| 36C25626D0074 | BRANCH MEDICAL LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $0 | FY2026 |
| 36C25626N0480 | LAREDO TECHNICAL SERVICES, INC. | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $634,046 | FY2026 |
| 36C25626D0045 | SS MEDICAL, INC. | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $0 | FY2026 |
| 36C25626D0037 | ROTECH HEALTHCARE INC. | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25616J1837_3600_VA25612D0363_3600 · retrieved 2026-09-26.